NCT04526886View on ClinicalTrials.gov

Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 15, 2020

Primary Completion Date

March 7, 2023

Study Completion Date

March 7, 2023

Conditions
Colorectal CancerGastric CancerEsophageal CancerAmpullary CancerSmall Bowel CancerAppendix Cancer
Interventions
OTHER

Algorithm for cytopenia-related delay and dose-reduction of mFOLFOX chemotherapy

Chemotherapy dose-adjustment algorithm for FOLFOX chemotherapy

Trial Locations (1)

03756

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT04526886 - Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy | Biotech Hunter | Biotech Hunter